TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BBOT

BridgeBio Oncology Therapeutics, Inc.

Healthcare · Biotechnology

4.00$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Investor relations

Report Dates

Investor relations overview for BridgeBio Oncology Therapeutics, Inc. (BBOT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/11/2026.

Next report 11/11/2026
Last report 08/11/2026
Earnings surprise by quarter (%)
Q3 25 · -202.9 % 25 Q4 25 · 25.8 % 25 Q1 26 · -102,777.3 % 26 Q2 26 · -29.1 % 26

EPS estimate beaten

Full history 1 of 4 quarters (25%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 BridgeBio Oncology Therapeutics, Inc. (BBOT): Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?